摘要
动脉粥样硬化(AS)是危害人类健康的主要疾病之一,其发病机理至今尚未完全阐明,研究主要是围绕三种学说,即脂质浸润学说、血栓形成学说和损伤反应学说。近年来Ross指出AS是炎症性疾病,这一观点得到了广泛认同。
出处
《江西医药》
CAS
2007年第3期262-264,共3页
Jiangxi Medical Journal
参考文献20
-
1Russell Ross.Atherosclerosis--an inflammatory disease.N Engl J Med,1999,340:115
-
2Despres JP,Lamarche B,Mauriege P,et al.Hyperinsulinemia as an independent risk factor for ischemic heart disease.N Engl J Med,1996,334:952
-
3Eschwege E,Richard JL,Thibult N,et al.Coronary heart disease mortality in relation with diabetes,blood glucose and plasma insulin levels.The Paris Prospective Study,ten years later.Horm Metab Res Suppl,1985,15:41
-
4Pyorala M,Miettinen H,Laakso M,et al.Plasma insulin and all-cause,cardiovascular,and noncardiovascular mortality:the 22-year followup results of the Helsinki Policemen Study.Diabetes Care,2000,23:1097
-
5Festa A,D Agostino RJr,Mykkanen L,et al.Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance.The Insulin Resistance Atherosclerosis Study (IRAS).Arterioscler Thromb Vasc Bio1,1999,19:562
-
6Wagenknecht LE,Zaccaro D,Espeland MA,et al.Diabetes and progression of carotid atherosclerosis:the insulin resistance atherosclerosis study.Arterioscler Thromb Vasc Biol,2003,23:1035
-
7Burchfiel CM,Sharp DS,Curb JD,et al.Hyperinsulinemia and cardiovascular disease in elderly men:the Honolulu Heart Pro,am.Arterioscler Thromb Vasc Biol,1998,18:450
-
8Yanase M,Takatsu F,Tagawa T,et al.Insulin resistance and fasting hyperinsulinemia are risk factors for new cardiovascular events in patients with prior coronary artery disease and normal glucose tolerance.Circ J,2004,68:47
-
9Sowers JR.Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology.Hypertension,1997,29:691
-
10Tran QK,Watanabe H,Le HY,et al.Insulin inhibits coronary endothelial cell calcium entry and coronary artery relaxation.J Cardiovasc Pharmacol,2001,38:885
同被引文献44
-
1邱宇安,黄绍烈,陈岳青,陈文学,黄秀珍.血管紧张素Ⅱ对内皮细胞致凋亡效应及血脂康的保护作用[J].江西医学院学报,2005,45(2):11-14. 被引量:4
-
2隆敏,覃军.一种新的内源性血管活性物质——胍丁胺[J].中国动脉硬化杂志,2005,13(5):653-654. 被引量:1
-
3Ross R.Atherosclerosis: an inflammatory disease [J].N Engl J Med, 1999,340(2):115-126.
-
4Libby P,Ridker PM,Maseri A.Inflammation in atherosclcrosis [J]. Circulation,2002,105(9):1 135-1 143.
-
5Boyle JJ.Macrophage activation in atherosclerosis: Pathogenesis andpharmacology of plaque rupture [J].CurrVasc Pharmacol,2005,3(1): 63 -68.
-
6DeGraba TJ.Immtmogenetic suspectibility of atherosclerotic slroke. Implications on current and future treatment of vaselular inflammation[J]. Stroke,2004, 35(suppll):2 712-2 719.
-
7Latkovskis G, Licis N, Kalnins U. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease [J].Eur J Immunogenet,2004,31 (5): 207-213.
-
8Dubravec DB, Spriggs DILMannick JA, et al.Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha[J].Proc Natl Acad Sci USA,1990,87:6 758-6 761.
-
9Ishai L,RonniG,David P, et al.Elevatcd levels of CRP in ovarian hyperstimulation syndrome: an unrecognised potential hazard [J]. B JOG,2005,112(7):952-955.
-
10Pau E,Alonso-Muriel I, Go mez R, et al.Plasma levels of soluble vascular endothelial growth factor receptor-I may determine the onset of early and late ovarian hyperstimulation syndrome [J].Hum Reprod,2006,21(6):1 453-1 460.
二级引证文献9
-
1马轶文,马东明,卢斌,姜希娟.银杏内酯B对动脉粥样硬化家兔模型血清CRP和主动脉VCAM-1 mRNA的影响[J].天津中医药大学学报,2010,29(2):84-86. 被引量:5
-
2蓝晓红,周永刚.血管活性物质与动脉粥样硬化的相关性研究概况[J].解放军药学学报,2010,26(4):353-357. 被引量:2
-
3谢丽华,侯玉立.实验性动脉粥样硬化过程中凝血指标动态变化[J].山西医科大学学报,2012,43(2):84-87. 被引量:3
-
4谢丽华,侯玉立.动脉粥样硬化过程中血浆纤维蛋白原动态变化研究[J].中国药物与临床,2012,12(3):294-296. 被引量:6
-
5蓝晓红,周永刚,李祥,许锐.三种联合用药方案对大鼠动脉粥样硬化及脂肪的影响[J].中华医学杂志,2012,92(23):1635-1640. 被引量:8
-
6陈君君,戴敏,陈鹏.丹皮酚对脂多糖诱导大鼠血管内皮细胞黏附的影响[J].中药材,2013,36(3):433-437. 被引量:5
-
7杨军,邝孛,王苏燕,江振涛,文格波.ACS患者外周血巨噬细胞炎性蛋白1α水平与血浆纤维蛋白原的关系[J].临床心血管病杂志,2014,30(1):43-45. 被引量:2
-
8彭金祥.化瘀复元胶囊对不稳定性心绞痛患者hs-CRP和Lp-PLA2水平的影响观察[J].云南中医中药杂志,2014,35(12):8-10. 被引量:1
-
9王霞.抗氧化、抗血小板和调脂三联疗法联合蒲参胶囊治疗颈动脉粥样硬化斑块的疗效观察[J].卫生职业教育,2016,34(12):139-140. 被引量:2
-
1徐也鲁.动脉粥样硬化——一种慢性炎症过程[J].中国动脉硬化杂志,2001,9(2):93-95. 被引量:187
-
2游陆,赵莹,王伟.免疫炎症反应与动脉粥样硬化斑块稳定性的关系[J].牡丹江医学院学报,2005,26(2):43-46.
-
3秦绪珍,唐国栋,邹雄.髓过氧化物酶,全新的心血管疾病检测标记物[J].医学检验与临床,2004,16(3):26-27. 被引量:2
-
4石惠荣,张金凤,张文杰,孙咏梅.单核细胞趋化因子-1和高敏C反应蛋白与动脉粥样硬化的研究进展[J].临床荟萃,2006,21(7):529-531. 被引量:7
-
5姜晓峰,梁红艳.细胞因子介导的信号转导途径与动脉粥样硬化关系的研究进展[J].中华检验医学杂志,2005,28(2):212-214. 被引量:1
-
6孙超君,唐其柱,魏捷,刘文卫,江华.白介素17在冠心病中的作用机制及临床意义[J].临床急诊杂志,2017,18(2):158-160. 被引量:5
-
7孟永霞,高春瑞,胡渝生,浦奎,李惠敏,王林,陈萍.急性心肌梗死患者血脂与前列环素、血栓素相关性的研究[J].岭南心血管病杂志,1999,5(4):269-271. 被引量:1
-
8吕海莉,王彦辉,刘宽芝.炎症因子与2型糖尿病动脉粥样硬化[J].中国实用内科杂志,2005,25(4):370-372. 被引量:30
-
9梁海峰,杨明.血小板活化与冠心病[J].山东医药,2010,50(20):107-108. 被引量:5
-
10张红雨,宋善俊.TAT、FPA、D-dimer与缺血性心脏病的关系[J].国外医学(输血及血液学分册),1993,16(1):23-25. 被引量:1